Search on our site

i.e.: vidatox, lung cancer or monoclonal antibodies. You can use any regular expression or word chain. Expressions with special character (') won't produce any result.

 followus black
Seguici su Facebook Seguici su Twitter Seguici su Linkedin Seguici su Google Seguici su YouTube

Blog AirGoesMagic

Su questo blog è possibile parlare di temi aeronautici e di salute che riguardano i nostri programmi.

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Team Blogs
    Team Blogs Find your favorite team blogs here.
  • Login
    Login Login form

NGF Levels in Parkinson’s disease Patients

by in Programma Neurologico (CIREN)
  • Font size: Larger Smaller
  • Hits: 3384
  • 0 Comments
  • Subscribe to this entry
  • Print
3384

 

Centro Internacional de Restauración Neurológica (CIREN), La Habana, Cuba.

 

Nerve Growth Factor (NGF) is a well-characterized protein with growth and survival promoting effects on specific neuronal populations. However, many questions remain unsolved concerning the role of NGF in the pathogenesis of any disease; especially in relation to various human clinical conditions such as Parkinson´s disease (PD).

NGF distribution can be studied with the use of a sensitive two-site enzyme immunoassay (EIA). We have now explored serum NGF levels in 44 PD patients in different stages of the disease (Grade: I, II, III and IV of Hoenh and Yahr scale) using an EIA with the monoclonal antibody 27/21 and a blocking test validating the specificity of the immunoreactivity for NGF. We found significant lower levels of specific NGF immunoreactivity in Parkinson sera (p<0.05). The NGF levels in early states of the disease (Grade I, II) showed greater reduction when compared with advanced stages (Grade III, IV). These data can suggest a relationship between serum NGF levels and the neurodegenerative changes observed in PD.

 

 

Comments

  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest Sunday, 27 September 2020